<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies</h2>
    <div class="badge">2025-09-09T10:35:00+00:00</div>
    <ul>
      <li>Global Hepatitis D Market (by Diagnostic Methods), Value ($million), 2023-2035 3.1 Blood Tests 3.2 Imaging Techniques 4.</li>
<li>4.1.3.2 Canada 4.2 Europe 4.2.1 Market Dynamics 4.2.2 Market Sizing and Forecast 4.2.3 Europe Hepatitis D Market, by Country ($Million), 2023-2035 4.2.3.1 U.K.</li>
<li>Global Hepatitis D Market (by Region), Value ($Million), 2023-2035 4.1 North America 4.1.1 Market Dynamics 4.1.2 Market Sizing and Forecast 4.1.3 North America Hepatitis D Market, by Country ($Million), 2023-2035 4.1.3.1</li>
<li>09, 2025 (GLOBE NEWSWIRE) -- The &quot;Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035&quot; report has been added to ResearchAndMarket</li>
<li>Key Topics Covered: 1.</li>
<li>Global Hepatitis D Market (by Treatment Type), Value ($million), 2023-2035 2.1 Antiviral Medications 2.2 Immunotherapies 2.3 Combination Therapies 3.</li>
<li>Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies The hepatitis D market is expanding due to increased diagnosis rates and ad</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies\n• Global Hepatitis D Market (by Diagnostic Methods), Value ($million), 2023-2035 3.1 Blood Tests 3.2 Imaging Techniques 4.\n• 4.1.3.2 Canada 4.2 Europe 4.2.1 Market Dynamics 4.2.2 Market Sizing and Forecast 4.2.3 Europe Hepatitis D Market, by Country ($Million), 2023-2035 4.2.3.1 U.K.\n• Global Hepatitis D Market (by Region), Value ($Million), 2023-2035 4.1 North America 4.1.1 Market Dynamics 4.1.2 Market Sizing and Forecast 4.1.3 North America Hepatitis D Market, by Country ($Million), 2023-2035 4.1.3.1\n• 09, 2025 (GLOBE NEWSWIRE) -- The &quot;Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035&quot; report has been added to ResearchAndMarket\n• Key Topics Covered: 1.\n• Global Hepatitis D Market (by Treatment Type), Value ($million), 2023-2035 2.1 Antiviral Medications 2.2 Immunotherapies 2.3 Combination Therapies 3.\n• Hepatitis D Market Research Report 2023-2035 | Gilead, GSK, and Janssen Drive Innovation as Biotechs Advance Antivirals, RNA, and Gene Therapies The hepatitis D market is expanding due to increased diagnosis rates and ad" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/hepatitis-d-market-research-report-103500907.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>